163 related articles for article (PubMed ID: 33439297)
1. Marine macroalga-associated heterotroph Bacillus velezensis as prospective therapeutic agent.
Francis A; Chakraborty K
Arch Microbiol; 2021 May; 203(4):1671-1682. PubMed ID: 33439297
[TBL] [Abstract][Full Text] [Related]
2. Marine macroalga-associated heterotrophic Bacillus velezensis: a novel antimicrobial agent with siderophore mode of action against drug-resistant nosocomial pathogens.
Chakraborty K; Francis A; Chakraborty RD; Asharaf S; Kizhakkekalam VK; Paulose SK
Arch Microbiol; 2021 Nov; 203(9):5561-5575. PubMed ID: 34436634
[TBL] [Abstract][Full Text] [Related]
3. Macrocyclic polyketides with siderophore mode of action from marine heterotrophic Shewanella algae: Prospective anti-infective leads attenuate drug-resistant pathogens.
Chakraborty K; Kizhakkekalam VK; Joy M
J Appl Microbiol; 2021 May; 130(5):1552-1570. PubMed ID: 33006801
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of marine macroalgae-associated heterotrophic bacteria.
Kizhakkekalam VK; Chakraborty K
Arch Microbiol; 2019 May; 201(4):505-518. PubMed ID: 30406296
[TBL] [Abstract][Full Text] [Related]
5. Novel amylomacins from seaweed-associated Bacillus amyloliquefaciens as prospective antimicrobial leads attenuating resistant bacteria.
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
World J Microbiol Biotechnol; 2021 Oct; 37(12):200. PubMed ID: 34664128
[TBL] [Abstract][Full Text] [Related]
6. Marine macroalgae-associated heterotrophic Firmicutes and Gamma-proteobacteria: prospective anti-infective agents against multidrug resistant pathogens.
Kizhakkekalam VK; Chakraborty K
Arch Microbiol; 2020 May; 202(4):905-920. PubMed ID: 31897537
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological potential of seaweed-associated heterotrophic bacterium Bacillus atrophaeus.
Varghese C; Chakraborty K; Asharaf S
Arch Microbiol; 2022 Nov; 205(1):6. PubMed ID: 36449106
[TBL] [Abstract][Full Text] [Related]
8. Polyketide-derived macrobrevins from marine macroalga-associated Bacillus amyloliquefaciens as promising antibacterial agents against pathogens causing nosocomial infections.
Chakraborty K; Kizhakkekalam VK; Joy M
Phytochemistry; 2022 Jan; 193():112983. PubMed ID: 34695706
[TBL] [Abstract][Full Text] [Related]
9. Seaweed-associated heterotrophic bacteria: new paradigm of prospective anti-infective and anticancer agents.
Kizhakkekalam VK; Chakraborty K
Arch Microbiol; 2021 Apr; 203(3):1241-1250. PubMed ID: 33140140
[TBL] [Abstract][Full Text] [Related]
10. Anti-staphylococcal activity of a cyclic lipopeptide, C
Nam J; Alam ST; Kang K; Choi J; Seo MH
J Appl Microbiol; 2021 Jul; 131(1):93-104. PubMed ID: 33211361
[TBL] [Abstract][Full Text] [Related]
11. Moving away from traditional antibiotic treatment: can macrocyclic lactones from marine macroalga-associated heterotroph be the alternatives?
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
Appl Microbiol Biotechnol; 2020 Aug; 104(16):7117-7130. PubMed ID: 32621124
[TBL] [Abstract][Full Text] [Related]
12. A Leap Forward Towards Unraveling Newer Anti-infective Agents from an Unconventional Source: a Draft Genome Sequence Illuminating the Future Promise of Marine Heterotrophic Bacillus sp. Against Drug-Resistant Pathogens.
Chakraborty K; Kizhakkekalam VK; Joy M; Chakraborty RD
Mar Biotechnol (NY); 2021 Oct; 23(5):790-808. PubMed ID: 34523054
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of heterotrophic bacterial communities from the marine sponge Erylus discophorus (Astrophorida, Geodiidae).
Graça AP; Bondoso J; Gaspar H; Xavier JR; Monteiro MC; de la Cruz M; Oves-Costales D; Vicente F; Lage OM
PLoS One; 2013; 8(11):e78992. PubMed ID: 24236081
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic-active heterotrophic Firmicutes sheltered in seaweeds: can they add new dimensions to future antimicrobial agents?
Chakraborty K; Varghese C; Asharaf S; Chakraborty RD
Arch Microbiol; 2022 Feb; 204(3):183. PubMed ID: 35179656
[TBL] [Abstract][Full Text] [Related]
15. Difficidin class of polyketide antibiotics from marine macroalga-associated Bacillus as promising antibacterial agents.
Chakraborty K; Kizhakkekalam VK; Joy M; Dhara S
Appl Microbiol Biotechnol; 2021 Aug; 105(16-17):6395-6408. PubMed ID: 34415389
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of some mangrove sediment-associated bacillus isolates.
Rajan L; Chakraborty K; Chakraborty RD
Arch Microbiol; 2021 Jan; 203(1):67-76. PubMed ID: 32749660
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological potential of seaweed-associated heterotrophic Firmicutes.
Asharaf S; Chakraborty K
Lett Appl Microbiol; 2022 Oct; 75(4):1042-1054. PubMed ID: 35771159
[TBL] [Abstract][Full Text] [Related]
18. Seaweed-associated heterotrophic bacteria: are they future novel sources of antimicrobial agents against drug-resistant pathogens?
Asharaf S; Chakraborty K; Chakraborty RD
Arch Microbiol; 2022 Mar; 204(4):232. PubMed ID: 35355132
[TBL] [Abstract][Full Text] [Related]
19. Cyclo(D-Tyr-D-Phe): a new antibacterial, anticancer, and antioxidant cyclic dipeptide from Bacillus sp. N strain associated with a rhabditid entomopathogenic nematode.
Nishanth Kumar S; Dileep C; Mohandas C; Nambisan B; Ca J
J Pept Sci; 2014 Mar; 20(3):173-85. PubMed ID: 24353056
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial polyketides from Bacillus amyloliquefaciens associated with edible red seaweed Laurenciae papillosa.
Chakraborty K; Thilakan B; Raola VK; Joy M
Food Chem; 2017 Mar; 218():427-434. PubMed ID: 27719931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
